Research

Research Team Award Recipients Announced

April 18, 2019 | Categories: News, Research

The Melanoma Research Foundation (MRF) is pleased to announce the recipients of the Melanoma Research Foundation Breakthrough Consortium – Bristol-Myers Squibb (MRFBC-BMS) Young Investigator Research Team Award to Advance the Field of Translational Immuno-Oncology.

April 15, 2019 | Categories: News, Policy, Research

Guest Blog: What Gets Measured Gets Managed

March 14, 2019 | Categories: Ocular Melanoma, Research, Treatment

Guest blog post by Bertil Damato, MD, PhD, FRCOphth. Dr. Damato is a Senior Clinical Research Fellow at the Nuffield Department of Clinical Neurosciences in Oxford, United Kingdom and a member of the CURE OM Patient Registry Steering Committee.

The MRF Congratulates 2018 Nobel Prize Recipients

October 1, 2018 | Categories: News, Research

The Melanoma Research Foundation (MRF) extends its sincerest congratulations to James P. Allison, Ph.D. and Tasuku Honjo, MD, Ph.D, whose groundbreaking work in cancer immunotherapy has earned the Nobel Prize in Medicine.

MRF & MRA Commend Congress for $10 Million Melanoma Research Funding

September 20, 2018 | Categories: News, Policy, Research

WASHINGTON, DC – The Melanoma Research Alliance (MRA) and the Melanoma Research Foundation (MRF) commend the House and Senate Appropriations Committees for including $10 million in dedicated melanoma research funding in the Conference Agreement on the FY2019 Defense Appropriations bill, H.R. 6157.

Act Now! Congress Proposes $10 Million for Melanoma Research

August 24, 2018 | Categories: Causes, News, Policy, Research

The Melanoma Research Foundation (MRF) needs you right now! After more than a decade of advocacy by the MRF and supporters like you we are days away from securing $10 million in Department of Defense (DOD) funding for melanoma research!

Patient Input Needed: Clinical Trial Design

July 5, 2018 | Categories: Research, Treatment

As part of their Commitment to Patients and Caregivers, our partners at Novartis are working to make the clinical trial experience more patient-centric and widely accessible. To this goal, they are currently seeking melanoma patients who have participated in a clinical trial in the past two years and who are interested in serving on an advisory board.

What's Next: 

CURE OM Patient Registry Update

June 21, 2018 | Categories: News, Ocular Melanoma, Research

 

Update on the CURE OM Patient Reported Registry

CURE OM Research Grant Recipient Announced

June 14, 2018 | Categories: News, Ocular Melanoma, Research

Walter Fast, Ph.D.The Melanoma Research Foundation (MRF) is pleased to announce that Walter Fast, Ph.D. has been selected as the recipient of a one-year MRF CURE OM Pilot Proposal Focused on GNAQ/11 Mutant Uveal Melanoma. Dr. Fast is a Professor and the William I. Dismukes Fellow in Pharmacy, Division of Chemical Biology and Medicinal Chemistry, College of Pharmacy at the University of Texas at Austin.

Congress Proposes $80M in Cancer Research Funding

June 14, 2018 | Categories: News, Policy, Research

Congress Proposes $80 Million for Cancer Research Funding

Pages